Accelerant’s $4bn sale puts specialty capacity terms under scrutiny

Thoma Bravo’s acquisition of a data-driven risk exchange raises questions about underwriting continuity for brokers

Nov 13, 2026 - 10:00
 0  0
Accelerant’s $4bn sale puts specialty capacity terms under scrutiny
Thoma Bravo’s acquisition of a data-driven risk exchange raises questions about underwriting continuity for brokers

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow